期刊文献+

乳腺癌组织中Survivin、p53表达及其与MVD的相关性 被引量:4

Expression of Survivin and p53 and its Relation with MVD in Breast Carcinoma
下载PDF
导出
摘要 目的探讨Survivin、p53蛋白在乳腺癌组织中的表达及其与微血管密度(MVD)的相关性。方法采用免疫组织化学的二步法,检测56例乳腺癌组织中Survivin、p53蛋白的表达,应用Ⅷ因子染色免疫组织化学技术,检测乳腺癌组织中微血管密度。结果Survivin蛋白在乳腺癌组织中的阳性表达率为78.4%(44/55)。p53在乳腺癌组织中阳性表达率为35.7%(20/56)。微血管密度在Survivin阳性组中均数为44±3.79,在Survivin阴性组中均数为26.25±4.79,两组比较,P<0.05。微血管密度在p53阳性组中均数为39.25±6.50,在p53阴性组中均数为36.57±11.63,两组比较,P>0.05。结论Survivin蛋白在乳腺癌的发生、发展中起重要作用,可能与乳腺癌浸润转移有关。Survivin和p53可能通过不同途径参与乳腺癌的凋亡和浸润转移。 Objective To study the expression of survivin and p53 and its relation with MVD in breast carcinoma. Methods Survivin and p53 protein were detected using immunohistochemical two-step method. MVD was detected using immunohistochemical VIII factor method. Results The positive rate of survivin protein was 78.6% (44/55) in the 56 patients with breast carcinoma. The positive rate of p53 protein in 56 breast carcinomas was 35.7% (20/56). MVD was 44 ±3.79 and 26.25 ± 4.79 in the tissues with positive and negative expression of survivin protein ( P 〈 0.05 ). MVD was 39.25 ± 6.50 and 36.57 ± 11.63 in the tissues with positive and negative expression of p53 protein (P 〉 0.05 ). Conclusion Survivin protein might play an important role in the oncogenesis and development of breast cancer. Survivin and p53 may involved in the infiltration and metastasis by different biological mechanism.
出处 《实用癌症杂志》 2009年第2期138-140,共3页 The Practical Journal of Cancer
关键词 乳腺癌 SURVIVIN蛋白 微血管密度 Breast carcinoma Survivin protein MVD
  • 相关文献

参考文献2

二级参考文献13

  • 1[1]Adida C,Crotty PL.Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation [J]Am P Pathol, 1998,152(1):43~49.
  • 2[2]Weidir N,Folkman J,Pozza F,et al.Tumor angiogensis:a new significant an independent prognostic indicator in early-stage breast cacinoma[J].J Natl Cancer Inst,1992,84:1875.
  • 3[4]O′Connor DS,Schechner J,et al.Control of apoptosis during angiogenesis by survivinexpression in endothelial cells [J].Am J Pathol,2000,156(2):393~398.
  • 4[5]Mesri M,Morales-Ruiz M,Ackermann EJ,et al.Suppression of vascular endothelial growth factor-mediated end othelial cell protection by survivin targeting[J].Am J Pathol,2001,158(5):1757~1765.
  • 5[6]Papapetropoulos Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway[J].J of Biol Chem,2000,275(13):9102~9105.
  • 6Ambrosini G,Adida C,Altieri DC.A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma[J].Nat Med,1997,3(8):917-921.
  • 7Kawasaki H, Altieri DC, Lu CD, et al.Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer[J]. Cancer Res,1998,58(22): 5071-5074.
  • 8Sinicrope FA, Ruan SB, Cleary KR, et al.bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis[J]. Cancer Res,1995,55(1):237-241.
  • 9Lu CD, Altieri DC, Tanigawa N, et al.Expression of a novel anti-apoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas[J]. Cancer Res,1998,58(9):1808-1812.
  • 10Lane DP.p53,guardian of the genome[J]. Nature,1982,358(6381):15-16.

共引文献7

同被引文献54

  • 1王震宇.Survivin在乳腺癌中的表达及其与p53表达的关系[J].中国误诊学杂志,2004,4(8):1245-1246. 被引量:7
  • 2燕善军,张成斌,陶仪声,徐希岳.生存素的表达与胃癌细胞凋亡和生物学行为的关系[J].胃肠病学,2006,11(7):415-419. 被引量:3
  • 3薄爱华,程琳,李海峰,赵荧,张晓丽,邢立强.表皮生长因子受体与肿瘤发生及治疗的相关性[J].医学综述,2006,12(20):1238-1240. 被引量:15
  • 4肖继平,张莉,齐云,龚攀.uPA及VEGF在乳腺癌中的表达及意义[J].中国普通外科杂志,2007,16(1):93-96. 被引量:15
  • 5Sitarz R, Leguit PJ, de Leng WW, et al. The COX-2 promoter polymorphism-765G > C is associated with early-onset, conventional and stump gastric cancers. Mod Pathol,2008,21 (6) :685-690.
  • 6Hino R,Uozaki H,Inoue Y,et al. Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein2A. Cancer Res ,2008,68 (5) : 1427-1435.
  • 7Williams CS, DuBois RN Prostagland in endoperox idesyn-thase: why two isoforms? Am J Physiol 1996,270 (3) :393.
  • 8Huang S, Armstrong EA, Benavente S, et al. Dual - agent molecular targeting of the epidermal growth factor receptor (EGFR) : combining anti - EGFR antibody with tyrosine kinase inhibitor [J]. Cancer Res, 2004, 64 (15): 5355.
  • 9Zhang Y, Zhang YF, Bryant J, et al. Intravenous RNA interference gene therapy targeting" the human epidermal growth factor receptor prolongs survival in intracranial brain cancer[J]. Clin Cancer Res, 2004, 10 (1) : 3667.
  • 10Kajivara Y, Yanasaki F, Hanas, et al. Expression of Survivin in astrocylic tumors correlation with malignant grade and prognosis [J]. Cancer, 2003, 97 (4): 1077.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部